Temat: "Substance Abuse, Intravenous" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Acceptability of a pilot motivational interviewing intervention at public health facilities to improve the HIV treatment cascade among people who inject drugs in Indonesia.
Autorzy:: Wongso LV; University Center of Excellence - AIDS Research Center, Health Policy and Social Innovation, Atma Jaya Catholic University of Indonesia, DKI Jakarta, 12930, Indonesia.
Rahadi A; University Center of Excellence - AIDS Research Center, Health Policy and Social Innovation, Atma Jaya Catholic University of Indonesia, DKI Jakarta, 12930, Indonesia. .
Sukmaningrum E; University Center of Excellence - AIDS Research Center, Health Policy and Social Innovation, Atma Jaya Catholic University of Indonesia, DKI Jakarta, 12930, Indonesia.; Faculty of Psychology, Atma Jaya Catholic University of Indonesia, DKI Jakarta, 12930, Indonesia.
Handayani M; Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Bandung, 40161, Indonesia.
Wisaksana R; Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Bandung, 40161, Indonesia.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Apr 01; Vol. 21 (1), pp. 73. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:: Journal Article
MeSH Terms:: Motivational Interviewing*/methods
HIV Infections*/drug therapy
Substance Abuse, Intravenous*/therapy
Substance Abuse, Intravenous*/drug therapy
Drug Users*
Humans ; Indonesia ; Anti-Retroviral Agents/therapeutic use ; Health Facilities

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma.
Autorzy:: Scaramutti C; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. .
Hervera B; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Rivera Y; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Chueng TA; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Forrest DW; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Suarez E Jr; Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Serota DP; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Alkamli H; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Ciraldo K; Department of Family and Community Medicine & Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Bartholomew TS; Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Tookes HE; 2Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Feb 23; Vol. 21 (1), pp. 50. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/therapy
Drug Users*
HIV Infections*/complications
HIV Infections*/therapy
Humans ; Health Services Accessibility ; Harm Reduction ; Perceived Discrimination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
Autorzy:: Lopes SS; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Pericot-Valverde I; Department of Psychology, College of Behavioral, Social, and Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Lum PJ; Department of Medicine, University of California, San Francisco, 1001 Potrero Ave, 94110, San Francisco, CA, USA.
Taylor LE; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, 7 Greenhouse Road, 02881, Kingston, RI, USA.
Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E6546, 21205, Baltimore, MD, USA.
Tsui JI; Department of Medicine, University of Washington, 325 9th Ave, 98104, Seattle, WA, USA.
Feinberg J; Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, 930 Chestnut Ridge Road, 26505, Morgantown, WV, USA.; Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, 1 Medical Center Drive, 26506, Morgantown, WV, USA.
Kim AY; Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St, 02114, Boston, MA, USA.; Harvard Medical School, 02115, Boston, MA, USA.
Norton BL; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Page K; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Murray-Krezan C; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, 15213, Pittsburgh, PA, USA.
Anderson J; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Karasz A; UMass Chan Medical School, University of Massachusetts Medical School, 55 Lake Ave, North, 01605, Worcester, MA, USA.
Arnsten J; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Moschella P; Department of Emergency Medicine, Prisma Health, Greenville, SC, USA.; School of Health Research, Clemson University, Clemson, SC, USA.; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA.
Heo M; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA. .; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA. .; Department of Medicine, Prisma Health, 29605, Greenville, SC, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 251. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Users*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C*/complications
Humans ; Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
Autorzy:: Goodman-Meza D; Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave., CHS 52-215, Los Angeles, CA, 90095-1688, USA. .
Shoptaw S; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Hanscom B; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Seattle, WA, USA.
Smith LR; Division of Infectious Diseases and Global Public Health, University of California, San Diego, San Diego, CA, USA.
Andrew P; Family Health International (FHI 360), Durham, NC, USA.
Kuo I; Milken Institute School of Public Health Department of Epidemiology, George Washington University, Washington, DC, USA.
Lake JE; UTHealth-Houston, Houston, TX, USA.
Metzger D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Morrison EAB; ICAP, Mailman School of Public Health, Columbia University, New York, NY, USA.
Cummings M; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Fogel JM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Richardson P; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Harris J; Family Health International (FHI 360), Durham, NC, USA.
Heitner J; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Stansfield S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
El-Bassel N; School of Social Work, Columbia University, New York, NY, USA.; Pokaż więcej
Corporate Authors:: HPTN 094 Study Team
Źródło:: Trials [Trials] 2024 Feb 15; Vol. 25 (1), pp. 124. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/complications
Drug Users*
HIV Infections*/diagnosis
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Sexually Transmitted Diseases*/diagnosis
Sexually Transmitted Diseases*/epidemiology
Sexually Transmitted Diseases*/prevention & control
Opioid-Related Disorders*/diagnosis
Opioid-Related Disorders*/epidemiology
Opioid-Related Disorders*/prevention & control
Humans ; Pharmaceutical Preparations ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Prevalence and factors associated with psychological distress among key populations in Nigeria.
Autorzy:: Ochonye B; Research and Development Department, Heartland Alliance, Abuja, Nigeria.
Emmanuel G; Research and Development Department, Heartland Alliance, Abuja, Nigeria.
Abang R; Research and Development Department, Heartland Alliance, Abuja, Nigeria.
Sanni OF; Research and Development Department, Heartland Alliance, Abuja, Nigeria.
Umoh P; Research and Development Department, Heartland Alliance, Abuja, Nigeria.
Kalaiwo A; Program Management, USAID, Abuja, Nigeria.
Mwoltu N; Research and Development Department, Heartland Alliance, Abuja, Nigeria.
Amechi P; Research and Development Department, Heartland Alliance, Abuja, Nigeria.
Motilewa O; Department of Community Medicine, University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0300901. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/epidemiology
Substance Abuse, Intravenous*
Sex Workers*
Sexual and Gender Minorities*
Psychological Distress*
Male ; Humans ; Female ; Homosexuality, Male/psychology ; Nigeria/epidemiology ; Prevalence ; Cross-Sectional Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets.
Autorzy:: Petkevičienė J; Health Research Institute, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, LT47181, Kaunas, Lithuania. .; Department of Preventive Medicine, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, LT47181, Kaunas, Lithuania. .
Voeller A; Center for Disease Analysis Foundation, 1120 W South Boulder Rd, Suite 102, Lafayette, CO, USA.
Čiupkevičienė E; Health Research Institute, Faculty of Public Health, Lithuanian University of Health Sciences, Tilžės str. 18, LT47181, Kaunas, Lithuania.
Razavi-Shearer D; Center for Disease Analysis Foundation, 1120 W South Boulder Rd, Suite 102, Lafayette, CO, USA.
Liakina V; Faculty of Medicine, Vilnius University, Universiteto str. 3, LT01513, Vilnius, Lithuania.; Faculty of Fundamental Sciences, Vilnius Tech, Saulėtekio av. 11, LT10223, Vilnius, Lithuania.
Jančorienė L; Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Santariškių str. 14, 08406, Vilnius, Lithuania.
Kazėnaitė E; Faculty of Medicine, Vilnius University, Universiteto str. 3, LT01513, Vilnius, Lithuania.; Vilnius University Hospital Santaros Klinikos, Santariškių str. 2, LT08661, Vilnius, Lithuania.
Zaksas V; National Health Insurance Fund under the Ministry of Health, Europos Sq. 1, LT03505, Vilnius, Lithuania.
Urbonas G; Department of Family Medicine, Lithuanian University of Health Sciences, Eivenių str. 2, LT50161, Kaunas, Lithuania.
Kupčinskas L; Department of Gastroenterology, Lithuanian University of Health Sciences, Eivenių str. 2, LT50161, Kaunas, Lithuania.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Apr 15; Vol. 24 (1), pp. 1055. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Users*
Substance Abuse, Intravenous*
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis C*/prevention & control
Male ; Female ; Humans ; Aged ; Lithuania/epidemiology ; Antiviral Agents/therapeutic use ; Seroepidemiologic Studies ; Hepacivirus ; World Health Organization ; Fibrosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Funding and Delivery of Syringe Services Programs in the United States, 2022.
Autorzy:: Facente SN; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Humphrey JL; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Akiba C; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Patel SV; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Wenger LD; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Tookes H; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Bluthenthal RN; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
LaKosky P; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Prohaska S; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Morris T; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Kral AH; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.
Lambdin BH; Shelley N. Facente is with the School of Public Health, University of California Berkeley. Jamie L. Humphrey, Christopher Akiba, Sheila V. Patel, Lynn D. Wenger, Terry Morris, Alex H. Kral, and Barrot H. Lambdin are with RTI International, Berkeley. Hansel Tookes is with the University of Miami, Miami, FL. Ricky N. Bluthenthal is with University of Southern California, Los Angeles. Paul LaKosky and Stephanie Prohaska are with the North American Syringe Exchange Network, Tacoma, WA.; Pokaż więcej
Źródło:: American journal of public health [Am J Public Health] 2024 Apr; Vol. 114 (4), pp. 435-443.
Typ publikacji:: Journal Article
MeSH Terms:: Needle-Exchange Programs*
Substance Abuse, Intravenous*
United States ; Humans ; Naloxone ; Benchmarking ; Public Health

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.
Autorzy:: Ceccarelli L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. .; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy. .
Moretti G; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Mazzilli S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Scuola Normale Superiore, Pisa, Italy.
Petri D; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Corazza I; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Rizzo C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Lucenteforte E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Vainieri M; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Seghieri C; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Tavoschi L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Pokaż więcej
Corporate Authors:: OPT-HepaC consortium
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 29; Vol. 24 (1), pp. 362. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/diagnosis
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Substance Abuse, Intravenous*/epidemiology
Male ; Pregnancy ; Female ; Humans ; Hepacivirus ; Retrospective Studies ; Antiviral Agents/therapeutic use ; Pandemics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs.
Autorzy:: Hinkes S; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA. .; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. .
Ciraldo K; Department of Obstetrics & Gynecology, University of Miami Miller School of Medicine, Miami, FL, USA.
Kobetz E; Division of Medical Oncology, Department of Medicine and Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Bartholomew TS; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Rinehart S; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Siringo N; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Barnett R; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Godbole N; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Jeanty F; Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, USA.
Frederick M; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Tookes HE; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Mar 27; Vol. 21 (1), pp. 70. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*
Drug Users*
Papillomavirus Infections*/prevention & control
Papillomavirus Infections*/diagnosis
Uterine Cervical Neoplasms*/prevention & control
Uterine Cervical Neoplasms*/diagnosis
Female ; Humans ; Vaccination ; Patient Acceptance of Health Care

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
Autorzy:: McKellar MS; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA. .
Des Marais AC; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Chen H; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Choi Y; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Lilly R; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.; Port City Harm Reduction, Wilmington, NC, USA.
Ayers D; Queen City Harm Reduction, Charlotte, NC, USA.
Bennett J; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.
Kestner L; Queen City Harm Reduction, Charlotte, NC, USA.
Perry B; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Poley S; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Corneli A; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA.; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Meade CS; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.; Wake Forest University, Winston-Salem, NC, USA.
Sachdeva N; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; North Carolina Association of County Commissioners, Raleigh, NC, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Mar 26; Vol. 21 (1), pp. 69. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/prevention & control
Opioid-Related Disorders*/drug therapy
Pre-Exposure Prophylaxis*
Substance Abuse, Intravenous*/drug therapy
Humans ; Male ; Buprenorphine, Naloxone Drug Combination/therapeutic use ; Pilot Projects ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysis.
Autorzy:: Krings A; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany. .
Steffen G; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.
Zimmermann R; Department of Infectious Disease Epidemiology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.; Pokaż więcej
Corporate Authors:: DRUCK 2.0-study group
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Mar 14; Vol. 21 (1), pp. 62. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/drug therapy
Drug Users*
Sexually Transmitted Diseases*
HIV Infections*/prevention & control
Hepatitis C*/epidemiology
Humans ; Feasibility Studies ; Pilot Projects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.
Autorzy:: Morgan B; Department of Medicine, Monash Health, Clayton, Australia. .
Lancaster R; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Boyagoda B; Central Clinical School, Monash University, Clayton, Australia.
Ananda R; Department of Medicine, Monash Health, Clayton, Australia.
Attwood LO; Central Clinical School, Monash University, Clayton, Australia.; Department of Infectious Diseases, Alfred Health, Clayton, Australia.; Monash Infectious Diseases, Monash Health, Clayton, Australia.
Jacka D; Addiction Medicine Unit, Monash Health, Clayton, Australia.
Woolley I; Central Clinical School, Monash University, Clayton, Australia. .; Department of Infectious Diseases, Alfred Health, Clayton, Australia. .; Monash Infectious Diseases, Monash Health, Clayton, Australia. .; School of Clinical Sciences, Monash University, Clayton, Australia. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 07; Vol. 24 (1), pp. 299. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
Drug Users*
Hepatitis C*
Soft Tissue Infections*/epidemiology
Arthritis, Infectious*
Adult ; Humans ; Male ; Female ; Retrospective Studies ; Bone and Bones ; Victoria

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Integration of Hepatitis C and Addiction Treatment in People Who Inject Drugs: The San Patrignano HCV-Free and Drug-Free Experience.
Autorzy:: Piselli P; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Boschini A; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Gianfreda R; Infectious Disease Unit, Hospital of Rimini 'Gli Infermi', 47923 Rimini, Italy.
Nappo A; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Cimaglia C; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Scarfò G; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Smacchia C; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Paoletti R; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Duehren S; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Girardi E; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 28; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Users*
Hepatitis C, Chronic*/drug therapy
Substance Abuse, Intravenous*/complications
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Reinfection ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: "No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
Autorzy:: Walker S; National Drug Research Institute, Curtin University, Perth, Western Australia, Australia. .; Burnet Institute, Melbourne, Victoria, Australia. .; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. .
Curtis M; National Drug Research Institute, Curtin University, Perth, Western Australia, Australia.; Burnet Institute, Melbourne, Victoria, Australia.
Kirwan A; Burnet Institute, Melbourne, Victoria, Australia.
Thatcher R; Access Health & 24/7 Needle and Syringe Program, Alcohol, Drugs and Other Addictions Stream, Victoria Social Mission Department, The Salvation Army Australian Territory, Melbourne, Victoria, Australia.
Dietze P; National Drug Research Institute, Curtin University, Perth, Western Australia, Australia.; Burnet Institute, Melbourne, Victoria, Australia.; Monash Addiction Research Centre, Monash University, Melbourne, Victoria, Australia.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Feb 24; Vol. 21 (1), pp. 51. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*
Illicit Drugs*
Humans ; Female ; Needle-Exchange Programs/methods ; Needles ; Victoria ; Naloxone/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Come back when you're infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023.
Autorzy:: Russell DM; Arizona State University, Tempe, AZ, USA.; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.
Meyerson BE; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA. .; Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA. .; Center for Comprehensive Pain and Addiction, University of Arizona Health Sciences, Tucson, AZ, USA. .
Mahoney AN; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Southwest Recovery Alliance, Phoenix, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.
Garnett I; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.; Center for Comprehensive Pain and Addiction, University of Arizona Health Sciences, Tucson, AZ, USA.
Ferrell C; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.; CAN Community Health, Phoenix, AZ, USA.
Newgass K; Southwest Recovery Alliance, Phoenix, AZ, USA.; Drug Policy Research and Advocacy Board (DPRAB), University of Arizona, Tucson, AZ, USA.
Agley JD; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.
Crosby RA; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; University of Kentucky College of Public Health, Lexington, KY, USA.
Bentele KG; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Southwest Institute for Research On Women, University of Arizona, Tucson, AZ, USA.
Vadiei N; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Frank D; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; School of Global Public Health, New York University, New York, USA.
Linde-Krieger LB; Harm Reduction Research Lab, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA.; Family and Community Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Feb 22; Vol. 21 (1), pp. 49. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:: Journal Article
MeSH Terms:: Pharmacies*
HIV Infections*/prevention & control
Substance Abuse, Intravenous*
Pharmacy*
Humans ; Syringes ; Arizona

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Loneliness and fearfulness are associated with non-fatal drug overdose among people who inject drugs.
Autorzy:: Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Ward K; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; School of Public Health, Drexel University, Philadelphia, PA, United States of America.
Wagner KD; School of Public Health, University of Nevada, Reno, NV, United States of America.
Karimi-Sari H; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Hsu J; Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Sulkowski M; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Latkin C; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Nwulia E; Department of Psychiatry, Howard University, Washington, DC, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0297209. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
Drug Users*
Drug Overdose*/epidemiology
Drug Overdose*/psychology
Humans ; Female ; Adult ; Middle Aged ; Male ; Loneliness ; Cross-Sectional Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital.
Autorzy:: Brooks HL; School of Public Health, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Speed KA; School of Public Health, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Dong K; Department of Emergency Medicine, Faculty of Medicine & Dentistry, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Salvalaggio G; Department of Family Medicine, Faculty of Medicine & Dentistry, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Pauly BB; Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.
Taylor M; Streetworks, Boyle Street Community Services, Edmonton, Alberta, Canada.
Hyshka E; School of Public Health, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 15; Vol. 19 (2), pp. e0297584. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
Humans ; Needle-Exchange Programs ; Needles ; Inpatients ; Policy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.
Autorzy:: Bromberg DJ; Yale School of Public Health, Yale University, New Haven, Connecticut, USA.; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, USA.; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Machavariani E; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Madden LM; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.; APT Foundation, New Haven, Connecticut, USA.
Dumchev K; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
LaMonaca K; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Earnshaw VA; University of Delaware, Newark, Delaware, USA.
Pykalo I; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Filippovych M; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Haddad MS; Center for Key Populations, Community Health Center, Inc., Middletown, Connecticut, USA.
Dvoriak S; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Altice FL; Yale School of Public Health, Yale University, New Haven, Connecticut, USA.; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, USA.; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.; University of Delaware, Newark, Delaware, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26202.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
HIV Infections*/drug therapy
HIV Infections*/prevention & control
HIV Infections*/complications
Humans ; Methadone/therapeutic use ; Analgesics, Opioid/therapeutic use ; Ukraine ; Primary Health Care

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Late Recurrence of Prosthetic Valve Endocarditis Due to Candida albicans.
Autorzy:: Al-Hashimi I; Office of Graduate Medical Education, University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Qazi M; Department of Medicine, University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Hickerson S; East Texas Infectious Disease Consultants, UT Health East Texas, Tyler, TX, USA.
Okon E; Department of Infectious Diseases, Christus Trinity Clinic, Tyler, TX, USA.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2024 Feb 01; Vol. 25, pp. e942399. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Endocarditis, Bacterial*/drug therapy
Substance Abuse, Intravenous*
Heart Valve Prosthesis*/adverse effects
Heart Valve Prosthesis*/microbiology
Endocarditis*/microbiology
Candidiasis*/diagnosis
Candidiasis*/drug therapy
Heart Valve Diseases*/etiology
Female ; Humans ; Adult ; Candida albicans ; Fluconazole/therapeutic use ; Micafungin/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder.
Autorzy:: Marks LR; Division of Infectious Disease, Washington University School of Medicine, Campus Box 8051, 4523 Clayton Avenue, St. Louis, MO, USA. .
Durkin MJ; Division of Infectious Disease, Washington University School of Medicine, Campus Box 8051, 4523 Clayton Avenue, St. Louis, MO, USA.
Ayres K; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Ellis M; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Jan 19; Vol. 21 (1), pp. 16. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:: Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/epidemiology
Opioid-Related Disorders*/epidemiology
Opioid-Related Disorders*/complications
HIV Infections*/complications
Humans ; Needle-Exchange Programs ; Harm Reduction ; Abscess ; Drug Compounding

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Substance Abuse, Intravenous"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język